Archive: 08/01/2018

Novo Nordisk woos Belgian nano-drug maker

Denmark's Novo Nordisk, the world's leading insulin manufacturer, announced Monday an offer to buy the Belgian biotech firm Ablynx for 2.6 billion euros ($3.1 billion).

page 4 from 9